| Characteristic | Buprenorphine* | Codeine** | Dihydrocodeine** | Ethylmorphine** | Hydrocodone | Morphine** | Oxycodone | Pholcodine** |
|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Region
Worldwide
Survey time period
2014 to 2023
Supplementary notes
Data before 2019 was taken from previous reports.
* An opiate currently controlled under the 1971 Convention.
** The consumption figures also include quantities used in manufacture of preparations listed in Schedule III of the 1961 Convention.
Citation formats









